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1. Introduction
Polycyclic aromatic hydrocarbons (PAHs) are a class of chemicals that contain multiple fused aromatic rings, 
and are emitted into the atmosphere as byproducts of burning organic matter (Keyte et al., 2013). Several 
PAHs have been identified as mutagenic or carcinogenic (Bostrom et al., 2002) and therefore have the po-
tential to harm the health of humans (Hansen et al., 2007; Park & Park, 2009) and ecosystems (Gray, 2002). 
In the atmosphere, PAHs are present as a complex mixture, with different people inhaling different combi-
nations of these carcinogens (Dixon et al., 2019). However, scientific research and environmental guidelines 
often represent this complex PAH mixture using a single surrogate compound, benzo[a]pyrene (BAP).
Epidemiological (Armstrong et al., 2004; Moolgavkar et al., 1998) and animal (Collins et al., 1991; Heinrich 
et al., 1994; Thyssen et al., 1981) studies have been used to estimate the cancer risk of human exposure to 
BAP, even though humans are exposed to many different kinds of PAHs. Risk estimates derived from epi-
demiological studies imply that exposure of 1 ng/m3 of BAP to a population of 1 million people will induce 
Abstract In assessments of cancer risk from atmospheric polycyclic aromatic hydrocarbons (PAHs), 
scientists and regulators rarely consider the complex mixture of emitted compounds and degradation 
products, and they often represent the entire mixture using a single emitted compound—benzo[a]pyrene. 
Here, we show that benzo[a]pyrene is a poor indicator of PAH risk distribution and management: nearly 
90% of cancer risk worldwide results from other PAHs, including unregulated degradation products 
of emitted PAHs. We develop and apply a global-scale atmospheric model and conduct health impact 
analyses to estimate human cancer risk from 16 PAHs and several of their N-PAH degradation products. 
We find that benzo[a]pyrene is a minor contributor to the total cancer risks of PAHs (11%); the remaining 
risk comes from other directly emitted PAHs (72%) and N-PAHs (17%). We show that assessment and 
policy-making that relies solely on benzo[a]pyrene exposure provides misleading estimates of risk 
distribution, the importance of chemical processes, and the prospects for risk mitigation. We conclude 
that researchers and decision-makers should consider additional PAHs as well as degradation products.
Plain Language Summary Nearly 90% of global human lung cancer risk from polycyclic 
aromatic hydrocarbons (PAHs) comes from compounds omitted by prior analyses and not regulated 
directly. PAHs in the atmosphere are a complex mixture, but regulators and researchers often represent 
them using a single compound, namely benzo(a)pyrene. We show that benzo(a)pyrene is a poor indicator 
of global PAH cancer risk; its use as a proxy leads to erroneous conclusions about high-risk populations 
and atmospheric chemical processes. We find that approximately 17% of risk comes from PAHs that 
are produced in atmospheric reactions and are not regulated or routinely monitored. Regulators and 
researchers should focus on the entire mixture of PAHs in the atmosphere, and we recommend that 
benzo(a)pyrene not be used as a sole reference compound.
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213–850 cancer cases over their lifetime (∼70 years). This is equivalent to an epidemiologically derived unit 
risk (UR
E
) that range from 213–850 × 10−6 per (ng/m3) (Armstrong et al., 2004; Moolgavkar et al., 1998). Ex-
isting epidemiological studies have not accounted for the confounding exposure to other PAHs, or exposure 
to other pollutants such as heavy metals, sulfur dioxide, and nitrogen oxide; applying UR
E
 thus implicitly 
reflects the impact of exposure to a mixture of PAHs. Cancer risks derived from studies in which animals 
were exposed to BAP alone are lower than those derived from epidemiological studies (UR
A
 = 0.3–1.7 × 10−6 
per [ng/m3]) (Collins et al., 1991; Thyssen et al., 1981) suggesting an increased risk associated with other 
components of PAH mixtures.
In global-scale modeling and air quality management, scientists and policy makers frequently use BAP as 
an indicator for calculating risk from the entire PAH mixture. Shen et al. (2014) and Shrivastava et al. (2017) 
estimate global-average human lung cancer risks of 20–31 × 10−6 by combining global-scale models of BAP 
in the atmosphere with an epidemiologically derived BAP unit risk. However, although estimates of UR
E
 
vary by a factor of ∼4, both Shen et al. (2014) and Shrivastava et al. (2017) test only the upper limit of this 
value. By using BAP as the sole indicator, these studies also assume that variations in BAP concentrations 
reflect proportional variations in risk. While PAHs are regulated as a class of substances, national and in-
ternational governing bodies also use BAP as an indicator for all species: BAP is the only PAH to have a 
guideline concentration.
In regional-scale modeling and field campaigns, scientists are able to capture a greater range of PAHs, 
but still neglect several highly toxic PAHs, and may double count the health effects of PAHs in cancer risk 
assessments. Toxic equivalent quotients (TEQs) are the toxicity of a compound relative to a reference com-
pound, and in the case of PAHs, the reference compound is BAP. Several studies estimate the cancer risk 
of individual components of PAHs mixtures by first using the TEQ to convert the PAH concentration to an 
equivalent concentration of BAP, and then combining it with estimates of UR
A
, through which the total 
cancer risk from PAHs can be estimated. In those studies, BAP is estimated as the major contributor to the 
cancer risk of PAHs (40%–80%) (Delgado-Saborit et al., 2011; Nielsen et al., 1996; Norramit et al., 2005; J. 
Zhang et al., 2016; Y. X. Zhang et al., 2009), but many of those studies do not include highly toxic emitted 
PAHs (e.g., dibenz[a,h]anthracene), and none include degradation products. An additional complication is 
that several such studies, however, use UR
E
 together with TEQs to assess combined risks from the mixture, 
which leads to a potential double-counting (Elzein et al., 2019; Zhang et al., 2016).
Recent work suggests that the atmospheric degradation products of PAHs, such as those containing a ni-
tro group (-NO
2
) that we refer to here as N-PAHs, are highly toxic, but their impact on human health 
remains uncertain. N-PAHs, including both nitro-PAHs (one -NO
2
 group) and dinitro-PAHs (two -NO
2
 
groups), can be up to 1,000 times more toxic than their respective parent compound (Wislocki et al., 1986). 
Laboratory studies have shown that N-PAHs are formed under several different oxidation reactions in the 
atmosphere (Keyte et al., 2013). N-PAHs have been detected in a variety of environments, from urban (Al-
binet et al., 2007; Elzein et al., 2019) to remote (Drotikova et al., 2020; Lammel et al., 2017). The chemical 
formation of N-PAHs in the atmosphere has been simulated in regional-scale (Mulder et al.,  2019) and 
global-scale (Wilson, 2020) atmospheric modeling studies; those studies, however, did not include a key 
particle-phase reaction with the nitrate radical (NO
3
) that laboratory studies suggest could be an extremely 
efficient source of N-PAHs (Zelenov et al., 2018; P. Zhang et al., 2014). Furthermore, as prior studies did not 
perform human health impact assessments, the importance of N-PAHs in the context of human health, as 
well as in relation to other advancements in this field, are both unknown.
Researchers in previous studies have argued that uncertainties in heterogeneous oxidation kinetics (Poschl 
et al., 2001; S. Zhou et al., 2019; S. M. Zhou et al., 2013) and gas-particle partitioning (Dachs & Eisenre-
ich, 2000; Shahpoury et al., 2016) have a large effect on exposure and human health impacts of BAP, but 
the importance of these uncertain processes in the context of other emitted PAHs and degradation products 
remains unknown. Shrivastava et al. (2017) found that reducing the rate of BAP heterogeneous oxidation 
resulted in a five-fold increase in estimated human exposure to BAP, and a three-fold increase in PAH hu-
man cancer risk when using BAP as an indicator of health risks. However, reductions in the oxidation rate 
will also diminish human exposure to degradation products, which may themselves be toxic—this effect 
was not considered by Shrivastava et al. (2017), who used BAP concentrations as a proxy for overall PAH 
exposure and risk. Additional studies (Friedman, Pierce, & Selin, 2014; Friedman & Selin, 2012; Friedman, 
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Zhang, & Selin, 2014; Mu et al., 2018; Thackray et al., 2015) have advanced understanding of PAH chemistry 
in the atmosphere through simulations of 1–3 PAH species. The sensitivity of process-based conclusions to 
the inclusion of additional PAHs and degradation products remains unassessed.
Here, we reevaluate the importance of BAP and its suitability as an indicator compound for global-scale 
cancer risk of PAHs, and we perform a bounding exercise to assess how uncertainties in concentrations and 
atmospheric processes affect conclusions drawn in previous studies which were based on BAP alone. To do 
this, we develop and use a global-scale atmospheric chemistry model to estimate concentrations of PAHs in 
the atmosphere, and use human health impact analyses to estimate the human cancer risk associated with 
atmospheric PAHs, using traditional epidemiologically based functions as well as a novel framework based 
on toxicity data from animal studies which allows us to explicitly estimate the risks of individual compo-
nents of the PAH mixture. In contrast to previous global-scale modeling studies which typically considered 
only BAP (Friedman, Pierce, & Selin, 2014; Friedman & Selin, 2012; Friedman, Zhang, & Selin, 2014; Lam-
mel et al., 2009; Mu et al., 2018; Octaviani et al., 2019; Shen et al., 2014; Shrivastava et al., 2017; Thackray 
et al., 2015), we account for the 16 PAHs identified as priority pollutants by the United Stated Environmen-
tal Protection Agency (“USEPA16”) as well as N-PAH degradation products. We quantify the sensitivity of 
estimates of global cancer risk to (a) inclusion of additional PAHs, (b) gas-particle partitioning, (c) heter-
ogeneous oxidation kinetics, and (d) model resolution. We conclude that BAP accounts for only a small 
(11%) fraction of the human cancer risk of PAHs globally, while the N-PAHs, which are unregulated and 
commonly omitted by measurement and modeling studies focused on the atmosphere, are a potentially 
large (17%) source of carcinogenic risk. We also find that atmospheric kinetic and partitioning uncertain-
ties have a much lower impact on risk magnitudes than was identified in previous studies. We suggest that 
future research and regulatory guidelines explicitly consider a broader range of PAHs and their degradation 
products in assessments of cancer risk from these compounds.
2. Materials and Methods
2.1. Experimental Design
We provide a total of 14 estimates of global human cancer risk from PAHs by combining seven different 
PAH concentration distributions from a global-scale atmospheric chemistry model, with two distinct meth-
ods for estimating human cancer risk. Together, this analysis allows us to quantify the suitability of BAP as 
an indicator of risk of PAH mixtures, and to bound the importance of contributors to uncertainty.
2.2. Description of Atmospheric Chemistry Model (GEOS-Chem)
We use a numerical, three-dimensional, atmospheric chemistry model, GEOS-Chem (Bey et al., 2001) ver-
sion 11. We perform model simulations at two different horizontal resolutions, of 4° × 5° and 2° × 2.5°—both 
with 47 vertical levels, extending from the surface of the Earth to ∼80 km altitude. Meteorological fields are 
driven by MERRA-2 reanalysis from the NASA Global Modeling and Assimilation Office (Global Modeling 
and Assimilation Office [GMAO]). We use the “tropchem” chemical mechanism (Eastham et al., 2014) for 




 and a bulk aero-
sol scheme with fixed log-normal modes. Aerosol components considered include sulphate, ammonium, 
nitrate, sea salt, black carbon, mineral dust, and organic carbon. Inorganic aerosol thermodynamics are 
calculated using ISORROPIA (Fountoukis & Nenes, 2007). Both OC and BC are further separated into hy-
drophilic and hydrophobic components. The tropchem mechanism is expanded to also consider PAHs (de-
scribed below Section 2.3). Dry deposition of both gases and aerosol are parameterized in a scheme which 
applies a resistance-in-series approach (Wesely, 1989; L. M. Zhang et al., 2001). Wet deposition occurs both 
within and below clouds, and is dependent on the species-specific effective Henry's Law constant (Amos 
et al., 2012). These model simulations use a variety of different global and regional-scale emission invento-
ries for non-PAH species. Global-scale emission inventories used here for non-PAH species include EDGAR 
(Crippa et al., 2018) and RETRO (Hu et al., 2015). Where necessary, these global-scale emission inventories 
are overwritten with regional-scale emission inventories—e.g., NEI over USA (Travis et al., 2016), EMEP 
over Europe (van Donkelaar et  al.,  2008). For biomass burning and biogenic emissions, we use GFED4 





greater detail in the following section. In the next sections, we describe how PAHs are simulated within the 
GEOS-Chem model, highlighting new developments.
2.3. Treatment of PAHs and N-PAHs in GEOS-Chem
The GEOS-Chem model has previously been used to examine PAH chemistry and transport in the at-
mosphere, both for the present day (Friedman, Pierce, & Selin, 2014; Friedman & Selin, 2012; Thackray 
et al., 2015) and future climate scenarios (Friedman, Zhang, & Selin, 2014). We extend the model (Friedman 
& Selin, 2012) such that PAHs are now fully interactive with other atmospheric species. This allows a two-
way chemical feedback between PAHs and all other gaseous and aerosol species. Previous simulations used 
an offline version of the model, whereby gas and aerosol concentrations from the “full” chemistry simula-
tion were archived and used as input for the PAH simulation.
Whereas previous modeling studies only consider between 1 and 3 PAHs, we extend the GEOS-Chem mod-
el to provide global-scale concentration information for a total of 48 PAH species. This consists of 16 emitted 
PAHs; the US EPA's list of priority PAHs. These include naphthalene (NAP), acenaphthylene (ACY), ace-
naphthene (ACE), fluorene (FLU), phenanthrene (PHEN), anthracene (ANT), fluoranthene (FLA), pyrene 
(PYR), benzo[a]anthracene (BAA), chrysene (CHR), benzo[b]fluoranthene (BBF), benzo[k]fluoranthene 
(BKF), benzo[a]pyrene (BAP), benzo[g,h,i]perylene (BGHIP), indeno[1,2,3-c,d]pyrene (ICDP), and diben-
z[a,h]anthracene (DAHA). The remaining 32 PAH species are the corresponding nitro-PAHs (×16) and 
dinitro-PAHs (×16).
Although commonly neglected from atmospheric modeling studies, we account for N-PAH formation in 
the atmosphere by building a chemical mechanism. We build a degradation mechanism of pyrene (PYR) 
that accounts for the formation of nitropyrene (nitro-PYR) and dinitropyrene (dinitro-PYR) (Table 1). This 
mechanism is generalized, as it is based on the findings from laboratory studies which are not all on pyrene. 
We chose pyrene for three reasons. First, pyrene is the only species where N-PAH formation yields have 
been determined in laboratory studies for each reaction pathway. Second, N-PYR is included in multiple 
field campaigns, allowing us to evaluate our predicted concentrations for this species. Many other N-PAHs 
have not been measured in the atmosphere. Third, the toxicity of N-PYR and DN-PYR are known, allowing 
us to quantify the human cancer risk of the oxidation products. The mechanism that describes the source 
and sinks for pyrene and its N-PAHs is displayed in Table 1. For this species, we account for the formation 
of nitropyrene via (a) gas-phase photooxidation, (b) gas-phase direct nitration, and (c) particle-phase direct 
nitration. Photolysis of the N-PYRs is also accounted for. For the remaining 15 emitted PAHs, the chemical 
mechanism only accounts for the chemical removal of the parent compound, and not the production of the 
N-PAHs. For these PAHs, we account for the major sinks (gas-phase photooxidation and particle-phase ozo-
nolysis), without directly tracking the products of chemical mechanism online in GEOS-Chem. This way of 
representing PAHs (i.e., the processes considered, and the neglect of oxidation products), is consistent with 
previous global and regional-scale modeling studies (e.g., Friedman & Selin, 2012). N-PAH concentrations 
from these 15 emitted PAHs are estimated in our bounding exercise and uncertainty analyses by applying 
the spatial distributions in the N-PYR/PYR and DN-PYR/PYR ratios (Figure S2) to concentrations of the 
remaining PAHs as a proxy for spatial patterns of their N-PAH products.
We provide two descriptions for heterogeneous oxidation kinetics which differ only by their reaction rate 
coefficients, allowing us to quantify how uncertainty in the rate of this process contributes to uncertainty 
in PAH distributions and human cancer risk. Within the GEOS-Chem model, particle-phase ozonolysis ki-
netics follow the Arrhenius equation using a second-order rate coefficient (k) from Perraudin et al. (2007). 
Although alternative laboratory studies show that heterogeneous PAH oxidation follows a Langmuir–Hin-
shelwood type reaction mechanism, implying that 
E k is variable (dependent on ozone), the parameters re-
quired to account for these more realistic descriptions of heterogeneous PAH oxidation kinetics have only 
been developed for a limited number of PAHs, and are not implemented in this study. However, as we know 
this process could be much slower, we conduct a sensitivity simulation where k is reduced to 10% of its 
laboratory-derived value.
We implement two widely used approaches to estimate gas-particle partitioning, allowing us to bound 





partition between gas and particle phases. In the particle phase, PAHs are observed to either be absorbed 
within organic aerosol (OA), or adsorbed onto the surface of black carbon (BC). We chose to implement a 
poly-parameter linear free energy (Shahpoury et al., 2016) (ppLFER) scheme, but for comparison, we also 
conduct simulations using a single parameter scheme following Dachs and Eisenreich (Dachs & Eisenre-
ich, 2000) (D&E).
PAH emissions for the year 2014 are from the global-scale emission inventory developed by Shen et al. (2013). 
This emission inventory is used widely across global-scale atmospheric modeling studies (Friedman, Pierce, 
& Selin, 2014; Friedman & Selin, 2012; Mu et al., 2018; Shrivastava et al., 2017; Thackray et al., 2015). The 
combined USEPA16 global-total annual-total emission rate is 504 Gg/a, with an interquartile range of 331–
818 Gg/a (Shen et al., 2013). The sectors included in this inventory are residential and commercial, industry, 
transportation, deforestation and wildfire, agriculture, and energy production.
Gas-phase PAHs undergo dry and wet deposition in a similar fashion to other gases. For all gas-phase spe-
cies, we assign a Henry's Law solubility constant of 3.1 × 10−5 m3 atm−1 mol−1, taken from Sander (2015). 
Particle-phase PAHs are assumed to undergo dry and wet deposition according to the aerosol that it is 
bound to—that is, dry and wet deposition parameters describing the aerosol particle are used to describe 
deposition of the particle-phase PAH.






 → NPYR 1.6 × 10−27 × [NO
2
] Atkinson et al. (1990) and Keyte et al. (2013)
R2. PYR
(g)
 + OH → PYR-OH 5.0 E  10−11 Atkinson et al. (1990)
R3. PYR-OH + O
2
 → products 1.0 E  10–17 Koch et al. (2007) (from benzene)
R4. PYR-OH + NO
2

















 → DNPYR 1.6 E  10−27 × [NO
2
] Identical to PYR
R9. NPYR
(g)
 + OH → NPYR-OH 5.0 E  10–11 Identical to PYR
R10. NPYR-OH + O
2
 → products 1.0 E  10–17 Koch et al. (2007) (from benzene)
R11. NPYR-OH + NO
2











 → products 2.2 E  10–17 Miet et al. (2009)
R14. NPYR
(p)






 → products 5.0 E  10–11 Identical to PYR
R16. DNPYR
(g)
 + OH → products 1.6 E  10−27 × [NO
2











 → products 2.2 E  10–17 Same as nitro-PYR
R19. DPYR
(p)
 + hv → products 1.3–5.0 E  10−4 Calculated based on photolysis cross sections of 
2-methyl-1-nitronaphthalene
Note. Chemical and photolytic reactions of pyrene (PYR) included in the updated version of the chemical-transport model (GEOS-Chem).
Table 1 





2.4. GEOS-Chem Model Simulations Performed in Study
We perform four global-scale model simulations, which are presented in Table 2. For all simulations, we 
discard the first month of simulation as spin up, and base our analysis on the remaining 12 months: Janu-
ary 2014–December 2014. For the base simulation, we use 4° × 5° horizontal resolution, second order rate 
coefficients describing heterogeneous oxidation kinetics are taken directly from the laboratory studies, and 
gas-particle partitioning follows the ppLFER scheme. We then perform three sensitivity simulations, where 
we change one parameter at a time, allowing us to isolate the importance of uncertainties in each of these 
processes. In the first sensitivity simulation, we reduce the heterogeneous oxidation rate coefficient to 10% 
of its original value (“Het_0.1”; Table 2). In the second sensitivity simulation, we change the gas-particle 
partitioning scheme from the ppLFER to the D&E scheme (“D&E”; Table 2). In the third sensitivity simu-
lation, we change the model horizontal resolution from 4° × 5° to 2° × 2.5° horizontal (“2 × 2.5”; Table 2).
2.5. Observations Used to Evaluate Simulated PAHs and Provide Simple Bias-Corrections
We use observations to evaluate performance of the four aforementioned GEOS-Chem model simulations, 
and also to provide three additional “bias-corrected” PAH concentration distributions (from the Base simu-
lation). Observations for Europe and North America were taken from continuously monitoring air quality 
networks (US Environmental Protection Agency Air Toxics Program; European Monitoring and Evaluation 
Program) and those for continental Asia (Saha et al., 2017), Asia-Arctic ship cruise transect (Ma et al., 2013), 
and Africa (Klánová et al., 2008) are from field campaigns. We apply three different “bias corrections” to the 
PAH distributions from the base simulation. In “PAH_Corr” (Table 2), we test for the effects of a bias in the 
differences in concentrations across the different PAHs, by multiplying the simulated PAH concentrations 
by the average bias between the simulated and observed mean PAH concentration across the non-urban 
sites (these bias-correction factors are shown in Table S2). In “N-PAH_Max” and “N-PAH_Min” (Table 2), 
we test for potential biases in simulated N-PAH/PAH yields by scaling the model-derived N-PAH/PAH ratio 
by the maximum/minimum bias between the simulated and observed N-PAH/PAH (these scaling factors 
are shown in Table S2). This provided upper and lower bound estimates for N-PAH formation potential.
2.6. Calculation of Incremental Lifetime Cancer Risk
We estimate the incremental lifetime cancer risk (ILCR) using two different methods. We combine these 
methods with PAH distributions from the 4 model simulations and 3 bias corrected model simulations, 
leading to a total of 14 different estimates of ILCR.
In the epidemiologically based method, we estimate ILCR (unitless) following.
    ILCR UR BAPE 
where UR
E
 is the epidemiologically derived BAP unit-risk (unit = per [ng/m3]), which is estimated at 21.3 
(Moolgavkar et al., 1998), 32.7 (Armstrong et al., 2004), 85.0 (Armstrong et al., 2004) ×10−6 per (ng/m3), 
Simulations Gas-particle partitioning Gas-particle partitioning scheme Resolution Bias-correction
Base Laboratory-derived ppLFER 4° × 5° None
Het_0.1 10% of laboratory value ppLFER 4° × 5° None
D&E Laboratory-derived D&E 4° × 5° None
2 × 2.5 10% of laboratory value ppLFER 2° × 2.5° None
PAH_Corr Laboratory-derived ppLFER 4° × 5° Corrected to PAH concentrations from
N-PAH_Min Laboratory-derived ppLFER 4° × 5° Corrected to minimum N-PAH yields
N-PAH_Max Laboratory-derived ppLFER 4° × 5° Corrected to maximum N-PAH yields
Note. Whereas the first four simulations in table are unique model simulations, the final three simulations are based on the Base simulation, but with various 
bias-correction techniques applied.
Table 2 





and [BAP] is the atmospheric concentration (ng/m3) of BAP, which is 
derived from the model. Under this method, overall ILCR is assumed 
to scale directly with BAP concentrations, and the impacts of the entire 
PAH mixture are accounted for (but the mixture is assumed to be fixed 
across the world).
We also develop an animal-based method for estimating ILCR, which 
allows us to compare the human cancer risk of individual PAH species 
without double counting. This is calculated as following
     AILCR UR PAH TEQ 
where UR
A
 is the animal-derived BAP unit risk (unit  =  per [ng/m3]), 
which is estimated by Collins et al. (1991) at 0.37 1.0, or 1.7 × 10−6 per 
(ng/m3), [PAH] is the atmospheric concentration (ng/m3) of PAHs, and 
TEQ are their toxic equivalent quotients (unitless). Where possible, we 
use estimates of TEQ from the primary literature, which have not been 
rounded to the nearest significant figure or order of magnitude, as is the 
case in many literature reviews; this rounding would introduce additional 
uncertainty in the relative importance of different PAHs. However, where 
the primary literature is not available, we use the recommended values 
from the literature reviews. TEQ used in this study from the literature 
are shown in Table 3. We use the terms TEQ and relative potency factor 
(RPF) interchangeably. This method assumes that the cancer risk of indi-
vidual PAHs combines linearly, as there is no conclusive evidence to sug-
gest otherwise. This animal-based method only includes the cancer risk 
of PAHs for which both exposure concentrations and toxicity information 
were available (28 of the 48 species: all 16 emitted of the emitted PAHs, 
6 out of the 16 nitro-PAHs, and 6 out of the 16 dinitro-PAHs). When at-
tributing ILCR to different PAHs in the animal-based method, we also 
account for possible biases in the simulated distribution of PAHs (i.e., dif-
ferences in concentrations among different PAH species). To account for 
the effect of possible biases, we used the “bias-corrected” spatial distributions of PAHs concentrations (see 
Table S1 for scaling factors). We also test for any biases in our predicted N-PAH/PAH ratios by performing 
sensitivity calculations, where these ratios are scaled using observed values (see Table S2 for scaling factors).
In the two equations above, the unit for the ILCR is cancer risk, and therefore dimensionless. We can com-
bine these risks with gridded human population density and assume a human lifetime of 70 years to express 
the ILCR in the form of cancer rates per year. Gridded human population density is taken from the Socio-
economic Data and Applications Center (SEDAC). Both of these methods for calculating ILCR are applied 
identically to all regions of the world. This means that while we account for regional variability in PAH 
exposure, we do not account for variability in human lifetime expectancy and cancer susceptibility, which 
are known to depend on a wide range of biological, environmental, and socioeconomic factors. However, 
using this relatively simple method for calculating ILCR ensure the results of this scoping study are easy to 
interpret and reproducible.
Across both methods for estimating ILCR, we test minimum, median, and maximum values of BAP toxicity 
(UR) from the literature. We also used both the epidemiological and animal-based methods to evaluate how 
uncertainties in heterogeneous oxidation kinetics affect estimates of PAH cancer risk, by applying them to 
two model simulations which differ in the reactivity of particle-phase PAHs. In the discussion, we provide a 
more detailed evaluation of advantages and disadvantages in the epidemiological- and animal-based meth-








FLA 0.052b 0.13b 0.13 (assumed)
PYR 0.065c 0.1c 5.1c
BAA 0.35c 0.1c 0.1 (assumed)
CHR 0.011b 10.8c 10.8 (assumed)
BBF 0.210000
BKF 0.03d
BAP - 0.47c 0.47 (assumed)
ICDP 0.08d
DAHA 3.0e 1.6e 1.6e
BGHIP 0.01a,f
Note. These values are used in the animal-based method for estimating 
ILCR. Note, we use the terms TEQ and RPF interchangeably.
aNisbet and Lagoy  (1992); bBusby et  al.  (1989); cWislocki et  al.  (1986); 
dDeutschwenzel, Brune, Grimmer, Dettbarn, and Misfeld (1983); eFu 
et al. (1998); fEPA (2009).
Table 3 






3.1. Global and Regional Concentrations of Emitted PAHs
We evaluate model performance of simulating 16 emitted PAHs by comparing simulated and observed PAH 
concentrations in a variety of environments. Simulated PAH concentrations were compared to a variety of 
different measurements and are displayed in Figure 1. In Figure 1, the simulated annual average surface 
concentrations for three illustrative PAHs are shown, and observed values are overlaid (circles). The left 
column shows three emitted PAHs, which are discussed in this section. The right column shows an emitted 
PAH and the N-PAHs degradation products, which are discussed in the next section.
Global PAH simulations are poorly constrained by available data, and many uncertainties exist in their 
emissions and atmospheric chemistry that affect the ability to model them accurately (see Global Model 
Performance in SI for more detail). As noted in Section 2.6, observations for Europe and North America 
were taken from continuously monitoring air quality networks (US EPA and EMEP) and those for con-
tinental Asia (Saha et  al.,  2017), Asia-Arctic ship cruise transect (Ma et  al.,  2013), and Africa (Klánová 
et al., 2008) are from field campaigns. Simulated and observed data at the location of measurements in Fig-
ure 1 are also represented in the form of box and whisker plots (Figure 2), where red reflects observed data, 
Figure 1. Spatial distributions of annual-average surface PAH concentrations (ng/m3) in the GEOS-Chem model and 
overlaid with observed values. The left column shows three emitted PAHs: (a) benzo[a]pyrene (BAP), (b) dibenzo[a,h]
anthracene (DAHA), and (c) f fluoranthene (FLA). The right column shows a parent compound and its N-PAH 
degradation products: (d) pyrene (PYR), (e) nitropyrene (nitro-PYR), and (f) dinitropyrene (dinitro-PYR). Circles 






green reflects our base simulation, and blue shows a sensitivity simulation to test the influence of chemical 
uncertainties (described below). In Figure 2, PAH species on the x-axis are ordered from lowest molecular 
weight (left) to highest molecular weight (right). A summary of statistics are also shown in the Supporting 
Information (Table S1).
The model captures average PAH concentrations for most PAHs, but with some low biases, especially in 
urban areas. For 11 out of 16 emitted species, the p-value is less than 0.05 (indicated by * in Figure 2). Over-
all, simulated PAH concentrations are lower than observed (Figure 2b). For 13 of the emitted species, the 
model underpredicts the observed global average PAH concentration (normalized mean bias (NMB) ranges 
from −97% to −42%; Figure 2b). For the remaining three emitted species (ACY, BKF, and DAHA) the model 
overestimates the observed global-average PAH concentration (NMB = 104%–464%; Figure 2b). For non-ur-
ban sites (i.e., outside of cities), simulated PAH concentrations are lower than observed over the United 
States, and higher than observed over Europe. The bias over the United States is likely a result of our choice 
of emission inventory: higher-resolution regional-scale emission inventories predict 2–3 times higher PAH 
emissions over the United States (J. Zhang et al., 2017) compared to the global-scale emission inventory 
used in this study (Shen et al., 2013). Similar to other global-scale models (Friedman & Selin, 2012), our sim-
ulation underpredicts the high observed PAH concentrations typical of urban environments (Figures 1a–1c; 
Figure 2. Box and whisker plot of PAH concentrations for all measurement sites displayed in Figure 1. Panel a shows concentrations (ng/m3), with red 
representing the observed data, green representing the base model simulation, and blue representing simulated PAH concentrations under the sensitivity 
simulation (a 90% reduction in the second order rate coefficients describing heterogeneous oxidation). The boxes denote the 25th and 75th percentiles, the 
whiskers denote the 5th and 95th percentiles, the horizontal line denotes the median, and dots denote outliers. Asterisks (*) indicate where p-value is less than 
0.05. Panel b shows the ratio of simulated to observed PAH concentrations (unitless), with green representing the base, and blue representing the sensitivity 
simulation. The 16 directly emitted PAHs considered are naphthalene (NAP), acenaphthylene (ACY), acenaphthene (ACE), fluorene (FLO), phenanthrene 
(PHEN), anthracene (ANT), fluoranthene (FLA), pyrene (PYR), benzo[a]anthracene (BAA), chrysene (CHR), benzo[b]fluoranthene (BBF), benzo[k]
fluoranthene (BKF), benzo[a]pyrene (BAP), benzo[g,h,i]perylene (BGHIP), indeno[1,2,3-c,d]pyrene (ICDP), and dibenz[a,h]anthracene (DAHA). Observations 





green circles), especially in cities across Asia and Africa. In remote regions, the model reproduces heavier 
molecular weight species measured across a ship cruise from Beijing (CH) to the Arctic (Ma et al., 2013), 
but underpredicts concentrations of lighter molecular weight species. In Svalbard (Norway), however, the 
model captures annual average PAH concentrations for the lighter molecular weight species, but underpre-
dicts the heavier molecular weight species by up to several orders of magnitude. Our model performance at 
capturing observed BAP concentrations is comparable to that of previous global-scale modeling studies (see 
Discussion section in the SI—Global Model Performance).
We further evaluated model performance at capturing differences in concentrations between the different 
PAHs, both globally and in different regions, which are important to capture the relative cancer risk of 
different species (not shown). The lighter PAH species are much more abundant than the heavier species, 
both globally (Figure 2a) and regionally. The model generally captures these relative differences in PAH 
concentrations. Nevertheless, we applied a simple “bias-correction” to the spatial distributions in PAH con-
centrations to test for the effects of a bias in the differences in concentrations across the different PAHs. Bias 
correction was conducted by multiplying the simulated PAH concentrations by the average bias between the 
simulated and observed mean PAH concentration across the non-urban sites (these bias-correction factors 
are shown in Table S1). These bias-corrected PAH concentration distributions were used in the cancer risk 
assessment in a sensitivity calculation.
To test the ability of the model to simulate the atmospheric lifetime of different PAHs, which affects the 
composition of PAH mixtures when comparing source and receptor environments, we examined concen-
tration gradients between Central Europe and the Arctic (Figure S1). The model captures the observed PAH 
concentration gradient between Kocetice (Czech Republic) and Svalbard (Norway) for most of the lighter 
weight PAH species (ACY, ACE, PHE, ANT, FLA, and PYR; Figure S1). The model underpredicts this gra-
dient for heavier PAHs (Figure S1). While uncertainties in lifetimes and emissions combine to influence 
concentrations at remote sites (Thackray et al., 2015), these biases in lifetime are large enough to offset the 
likely overestimates in European emissions. To test the importance of these biases, we used the model sen-
sitivity simulation that reduces the second order rate coefficient describing heterogeneous oxidation to 10% 
of its original value (“Het_0.1”). Lighter PAHs are insensitive to changes in heterogeneous oxidation kinet-
ics, as these species exist mostly in the gas-phase. The heavier molecular weight PAHs, which mostly exist 
in the particle-phase, are extremely sensitive to this sensitivity simulation. Under this simulation where 
heterogeneous oxidation kinetics are reduced to 10% of the value in the base simulation, the simulated 
PAH concentration gradients between Kocetice and Svalbard agree with observed values, and biases in PAH 
concentrations over Svalbard are minimized (Figure S1). We use this sensitivity simulation below to test 
the influence of uncertainties in heterogeneous oxidation on estimates of human cancer risk (Figure 3a).
For almost all continental regions, PAH concentrations are insensitive to uncertainties in gas-particle par-
titioning. The poly-parameter linear free energy relationship (ppLFER) gas-particle partitioning scheme 
used in the base model simulation captures observed particle fractions better than the D&E scheme used 
in the sensitivity simulation. While particle-phase fractions differed greatly between the two gas-particle 
partitioning schemes, annual-average PAH concentrations are within 5% of each other over most continen-
tal environments under the two schemes. This is because of the very small differences between simulated 
gas- and particle-phase lifetimes.
3.2. Global and Regional Concentrations of PAH Degradation Products
We estimated the atmospheric concentrations of N-PAHs (nitro-PAHs and dinitro-PAHs) for all 16 of the 
emitted PAH discussed above (Section 2.4). Within the GEOS-Chem model, the chemical mechanism for 
pyrene (PYR) accounts for the formation of N-PYR (nitro-PYR and dinitro-PYR) (Table 1). Oxidative pro-
cesses considered include gas-phase photooxidation (+OH) and direct nitration (+NO
3
), and heterogeneous 
ozonolysis (+O
3
) and direct nitration (+NO
3
), all of which contribute to N-PYR formation, except heteroge-
neous ozonolysis. For the remaining N-PAHs, which are not incorporated into the online chemical mech-
anism, concentrations of the N-PAHs were predicted offline by scaling concentrations of the remaining 
parent PAHs by spatially resolved ratios of nitro-PYR/PYR and dinitro-PYR/PYR (Figure S2). This approach 
recognizes that detailed atmospheric degradation data for each individual PAH are not available, and thus 





conditions. We used sensitivity calculations (described below) to further test the uncertainties introduced 
by this approach.
Simulated global mean atmospheric concentrations of nitro-PYR in the atmosphere are not statistically dif-
ferent from observations (p < 0.05, Figure 2b). Spatial patterns in the N-PAHs (nitro-PYR and dinitro-PYR) 
and the parent PAH, PYR, are very similar (Figures 1d–1f). Across non-urban sites, the model underpredicts 
the observed nitro-PYR concentration (0.016 ng/m3) by a factor of 2.5. This bias is due to a combination of 
two factors. First, the model underestimates pyrene, the parent compound, by a factor of 1.4, likely due to 
underestimates of emissions, as described above. Second, our simulated nitro-PYR/PYR ratio of 0.021, is 
lower (×0.6) than the observed value (0.036) across the aggregated data set of measurements, implying that 
we underestimate nitro-PAH formation on average. However, this is not consistent across all environments.
We compared the simulated N-PAH/PAH ratio to observed values from field campaigns, which measure the 
two species simultaneously (Table S2). The simulated nitro-PYR/PYR ratio lies within the range of estimates 
Figure 3. Global and regional impacts of ambient PAH concentrations on human cancer risk. Panel a shows a breakdown in global human cancer risk from 
different PAHs (%). Panel b shows global annual cancer rates (cancer cases a−1) induced by PAHs, as estimated by two different methods (epidemiologically 
based, and animal-based), and under three different model simulations (Base, Het_0.1, and 2 × 2.5). Estimates from the literature are also shown. Panel c 
shows the spatial pattern in PAH-induced human cancer rates under the base simulation, applying the animal-based method to estimate ILCR (but the pattern 
is similar for other formulations, which are not). Note that an ILCR of 1 × 10−6, applied to the global population (∼7 × 109) is equal to 7 × 103 lifetime cancer 





from field campaigns; our value is ×0.2, ×0.7, and ×3 times the value observed across China, France, Hun-
gary, respectively. These biases vary across the different PAH species, but there were no systematic patterns 
(Table S2). The simulated nitro-PAH/PAH ratios range from 2.0- to 4.0-fold of the observed ratios for FLA, 
0.2–3.0 fold of the observed ratios for PYR, 0.06–10 fold of the observed ratios for CHR, and 0.02–5.0 fold 
of the observed ratios for BAP. To account for the impact of potential biases in estimating the cancer risk of 
PAHs and N-PAHs, we conducted sensitivity calculations by scaling the model-derived N-PAH/PAH ratio 
by the maximum/minimum bias between the simulated and observed N-PAH/PAH (these scaling factors 
are shown in Table S2). This provides upper and lower bound estimates for N-PAH formation potential.
Heterogeneous direct nitration (+NO
3
) is the major source of N-PAHs in the atmosphere, as discussed in 
greater detail in the SI (Global and Regional Concentrations of PAH Degradation Products). Globally, heter-
ogeneous direct nitration accounts for 99% of nitro-PYR production in the model. In laboratory studies, this 
process is a combination of multiple elementary reaction steps. Because the exact mechanism is unknown, 
we simulated it here using a single-step reaction. Laboratory studies find that the yield of N-PAHs from this 
process ranges 0.04% (Zelenov et al., 2018)—100% (Ringuet et al., 2012). In our model, we assumed a fixed 
N-PAH formation yield, and chose 100% in order to bound this reaction pathway; despite this maximal as-
sumption, our model still underestimates the nitro-PYR/PYR ratio as discussed above.
The base simulation provides a better representation of the relative importance of parent PAHs and N-PAHs 
compared to the sensitivity simulation in which heterogeneous oxidation kinetics are reduced to 10% of 
their laboratory values. PYR is insensitive to assumptions in heterogeneous oxidation kinetics, as this chem-
ical reaction represents a minor removal term for this species compared with gas-phase oxidation. However, 
heterogeneous oxidation is the major source of N-PAHs, so as this process slows down, concentrations of 
N-PAHs reduce. Reductions in the heterogeneous oxidation rate reduce the model's ability to capture the 
observed N-PYR concentration and N-PYR/PYR ratio (Figure 2b). Hence, while slower oxidation improves 
reaction kinetics for heavier molecular weight PAHs as discussed above, it decreases the model's ability to 
capture the observed concentration of N-PYR.
3.3. Human Cancer Risk of Ambient PAH Mixtures
We calculated the incremental lifetime cancer risk (ILCR) of PAHs (Figure 3) using two different methods 
(Section 2.6). Briefly, the epidemiologically based method uses BAP as proxy for risk of the whole PAH mix-
ture, and the animal-based method accounts for regional variations in the PAH mixtures.
Using the animal-based method allowed us to compare the relative importance of different PAHs to ILCR 
(Figure 3a). BAP accounts for just 11% of the calculated global human cancer risk of the entire pollutant 
mixture, with the remaining emitted PAHs accounting for 72%, and the 12 N-PAHs (6 nitro-PAHs and 6 
dinitro-PAHs) for which toxicity information is available account for the remaining 17% of global ILCR 
(Figure 3a). The finding that BAP was of low importance to global human cancer risk (11%) contradicts 
the findings of previous studies, but was robust across all sensitivity calculations conducted here (5%–19%; 
Figure 3a). Across our sensitivity calculations designed to capture the entire range of observed nitro-PAH/
PAH ratios of the 6 PAHs considered, the contribution of N-PAHs to global ILCR ranges from 3% to 62% 
(Figure 3a). There are very few constraints on the nitro-PAH/PAH ratio; thus, we tested the limits of these 
values. While these sensitivity calculations gave some indication of the uncertainty related to the impor-
tance of N-PAHs, because each calculation used a single field study (i.e., single point) to constrain the 
entire global distribution of N-PAHs, they should be considered as extreme estimates for the importance of 
N-PAHs, and only applicable to environments close to where the field study is located. Despite these limi-
tations, our model results suggest that N-PAHs could contribute substantially to global human health, even 
though they are routinely neglected in risk assessments.
Under the animal-based method, PAHs induce a global annual total human lung cancer rate of 231/year, 
which is ∼3 times lower than the rate estimated under the epidemiologically based method (759/year, Fig-
ure 3b). As noted above, epidemiologically based methods implicitly address the impacts of mixtures of 
PAHs, because they are derived from studies in which people were exposed to multiple compounds simul-
taneously. Our animal-based method results in lower estimates because it includes only a small sample of 





animal-based method also does not include other groups of PAHs which may be extremely toxic, such as 
oxygenated, halogenated, and alkylated species (Andersson & Achten, 2015), and assumes that effects of 
individual PAHs add linearly. Thus, the overall magnitude of ILCR associated with PAHs is likely more 
realistic using the epidemiologically based method. However, the epidemiologically based method does not 
provide insight as to the toxicity and cancer risk of different chemical species and their respective degra-
dation products. Further, the magnitude and spatial distribution of risk predicted by the epidemiologically 
based method are only accurate to the extent that global PAH concentrations reflect the mixtures to which 
people were exposed in the original epidemiological studies, and the degree that the overall risk scales with 
changes in BAP concentration. Under both methods for estimating ILCR, global ILCR exceeds the com-
monly applied threshold level of 1 in 1,000,000 (1 × 10−6); this is comparable in magnitude to estimates from 
previous studies (Figure 3a). Under the epidemiologically based method for estimating human cancer risk 
of PAHs, 70 (63–82)% of the global population breathe air which exceeds this safe threshold level (with the 
ranging representing the upper and lower bounds in BAP toxicity).
Under the animal-based method, human cancer risk is much less sensitive to uncertainties in PAH het-
erogeneous oxidation kinetics than that reported in previous studies using BAP as an indicator species 
(Shrivastava et al., 2017). This is because when particle-phase PAHs are assumed to be less reactive, con-
centrations of the parent compounds increase, while concentrations of the oxidation products decrease. 
Previous studies, which have used the epidemiologically based method, only accounted for the former 
(increased human exposure to the parent compound), whereas the animal-based method used here also 
accounts for the latter (decreased concentrations of the degradation products). Compared to the base sim-
ulation (Base = 0.19 ng/m3), the global-average population-weighted BAP concentration is 90% higher in 
the sensitivity simulation that tests the impact of oxidation kinetics (Het_0.1 = 0.36 ng/m3). Under the 
epidemiology-based method for estimating ILCR, where the cancer risk of PAHs scales closely with BAP, 
global ILCR is 76% higher in the sensitivity simulation (1,335/year) compared to the standard version of the 
model (759/year). However, the animal-based method shows a much weaker sensitivity in global ILCR to 
particle-phase reactivity. For the same increase in BAP exposure (+90%), the global ILCR increases by only 
18%, from 231 to 273/year (Figure 3b). Under this method, while slower particle-phase reactivity increases 
human exposure to the parent compounds, this is partially offset by reductions in exposure to the oxidation 
products. The animal-based method thus provides a more realistic estimate of the impact of heterogeneous 
oxidation uncertainty on cancer risks. Human cancer risk is also insensitive to uncertainties in gas-particle 
partitioning. Both globally and regionally, the ILCR changes by less than 1% when the gas-particle partition-
ing scheme is changed from the ppLFER scheme used in the base model simulation, to the D&E scheme 
used in the sensitivity simulation. Similarly, when the model resolution is increased from 4° × 5° in the base 
simulation to 2° × 2.5° in a sensitivity simulation (“2 × 2.5”), global ILCR increases by 29%—however, the 
relative importance of each PAH species to global ILCR remains unchanged.
Although omitted from previous global-scale assessments, uncertainties in BAP toxicity also play a substan-
tial role in influencing the magnitude in global ILCR from PAHs. In Figure 3b, for our estimates of global 
ILCR, the length of the bars represents the uncertainty bounds in BAP toxicity, but for Shen et al. (2014) 
and Shrivastava et al. (2017), they represent uncertainties associated with genetic susceptibility and heter-
ogeneous oxidation kinetics, respectively. From Figure 3b, under the epidemiologically based method, un-
certainties associated with BAP toxicity (length of red and orange bars in Figure 3b) have a larger influence 
on global ILCR than uncertainties in genetic susceptibility (lengths of yellow colored bar in Figure 3b) and 
uncertainties in heterogeneous oxidation kinetics (length of peach colored bar in Figure 3b), highlighting 
the importance of future research on this parameter.
Under the epidemiologically based and animal-based methods, human cancer risk associated with PAHs 
is highest in urban and industrial regions, but the two methods differ in their assessments of the spatial 
variability of these risks. Both methods predict PAH exposure leads to the highest human cancer risk over 
regions such as China, India, Central, and Eastern Europe (Figure 3c). Under the epidemiologically based 
method, however, differences in ILCR are driven solely by BAP, whereas under the animal-based method, 
the ILCR varies spatially with BAP and many other PAHs. When assessing the impact on human cancer risk 
of reducing BAP emissions (not shown), the epidemiologically based method would estimate a proportional 





cancer risk a factor of three or more lower (which would vary based on the regional variations in the con-
tribution of BAP to total ILCR).
4. Conclusions
We developed and evaluated a new, global-scale model that accounts for 16 emitted PAHs in addition to 
their degradation products. We used this model to calculate the human cancer risk of exposure to these 
PAH mixtures using two different methods: an epidemiologically based method based on BAP concentra-
tions that quantifies overall risk, and an animal-based method that allowed us to attribute risk to individual 
components of the pollutant mixture without double counting. We then evaluated the relative importance 
of BAP to global risk, and assessed the utility of using BAP as an indicator compound.
We found that BAP is only a small contributor to the global human cancer risk of PAHs (11%), suggesting 
it is an inadequate indicator of human cancer risk from this pollutant mixture. Atmospheric modeling 
studies typically only consider a single PAH species (BAP), and our work suggests that conclusions based 
on modeling this single compound can be misleading or erroneous. In previous studies, BAP accounted for 
40%–80% of the cancer risk of PAHs (Delgado-Saborit et al., 2011; Nielsen et al., 1996; Norramit et al., 2005; 
Zhang et al., 2009, 2016). However, Zhang et al. (2016) only considered eight PAHs, which partially explain 
their high BAP contribution to ILCR over the United States (9–154/year) of 40%–60%. In our study, where 
we considered 16 emitted PAHs and 12 N-PAHs, BAP accounted for 5%–15% of ILCR over the same region. 
The assumed toxicity of DAHA (ranging from 1 to 10 times that of BAP), and whether it is even included, 
varies from study to study. Nielsen et al. (1996), who estimated that BAP accounts for 70% of cancer risk in a 
field study, did not include DAHA in their analysis. In addition, several highly toxic PAHs were not included 
in this study, due to lack of data to constrain their emissions and chemistry. Anderson and Achten (2015) 
argue that, in addition to the USEPA16 and N-PAHs, scientific research should be expanded further still, to 
include other highly toxic parent PAHs and degradation products with an oxy group (O-PAHs). However, at-
mospheric emission inventories are available only for the USEPA16, and current understanding of O-PAHs 
is insufficient to build chemical mechanisms within atmospheric models. However, including further PAHs 
and degradation products would almost certainly further diminish the importance of BAP, strengthening 
our main conclusions.
In addition to the emitted PAHs, we also considered N-PAHs, and we found them to be an important con-
tributor to human cancer risk, but unlike BAP and the other USEPA16, they are not regulated or rou-
tinely monitored. Previous assessments of the impact of N-PAHs were limited to a small number of field 
campaigns and a single box-model study. Our model simulations showed that wherever PAHs are emitted, 
there is sufficient NO
3
 to allow the formation of N-PAHs. Accounting for 15%–20% of the carcinogenic 
potential of PAH mixtures, we estimated that N-PAHs are comparably dangerous for human cancer risk 
to BAP (11%). In our sensitivity calculations, the uncertainty in N-PAH/PAH concentration ratios led to 
considerable variance in the contribution of N-PAH to human cancer risk. Increased confidence in this 
class of chemical would be provided by (a) a deeper understanding of the formation processes (yields and 
mechanisms), (b) a wider understanding of the toxicity of N-PAHs, and (c) greater geographical coverage 
and density of observations. Furthermore, in addition to being formed during the oxidation of parent PAHs, 
as simulated here, N-PAHs can also be directly emitted into the atmosphere. We do not consider direct emis-
sions of N-PAHs in our atmospheric model. Our simulations, however, are constrained by observed values 
of N-PAHs, thus we believe our result that N-PAHs contribute 15%–20% to global ILCR is a robust bounding 
estimate. Nevertheless, providing better constraints on the source of N-PAHs in the atmosphere should be 
a future research priority, especially if mitigation measures are to be considered.
PAHs and their degradation products, including N-PAHs, can have a complex impact on human cells, al-
tering transcriptional profiles, signaling networks, and in many cases causing DNA adducts that eventually 
can progress to DNA mutations. While most research has been focused on understanding the response 
of cells to single PAH species such as BAP, cancer risk data highlight the need to consider more complex, 
real-world mixtures of PAHs in order to better define the interactions between different compounds and 





PAHs pose a substantial threat to global human cancer risk across all of our simulations and the two meth-
ods for estimating ILCR. We estimated an overall annual cancer risk of 231–759/year from ambient ex-
posure to PAHs globally. Across each of the model simulations and methods in this study, as well as in 
previous studies, global ILCR exceeded the commonly applied threshold level of 1 in 1,000,000 (1 × 10−6) 
(Figure 3b). Our epidemiologically based estimate using our base simulation nevertheless calculated a low-
er global cancer risk than previous studies. Results from Shen et al. (2014) and Shrivastava et al. (2017) are 
shown for comparison in Figure 3b. Our estimates were lower for three reasons. First, Shen et al. (2014) and 
Shrivastava et al. (2017) choose to “downscale” their simulated BAP concentrations to reduce bias in urban 
environments, whereas we did not. Downscaling introduces additional uncertain parameters; we chose 
instead to apply the best available physical, process-based and explore the importance of simulation biases 
more directly through supplementary calculations. Second, we used median estimates of the toxicity of 
BAP, whereas Shen et al. (2014) and Shrivastava et al. (2017) used maximum estimates from the literature. 
Third, to facilitate comparison of the variability driven by the concentration of different PAHs, we did not 
account for variability in cancer susceptibility in either of our methods for estimating ILCR, which has been 
shown to double global ILCR.
Our animal-based method provides a more realistic description for spatial differences in the human cancer 
risk associated with PAHs, as it captures regional differences in PAH mixtures. For example, simulated an-
nual-average BAP concentrations were 3.5 times higher over Hong Kong compared to southern India. Using 
the epidemiologically based method, the calculated difference in ILCR between these two locations also dif-
fered by the same amount (×3.5), but the animal-based method suggested that cancer risk in Hong Kong is 
12 times higher than over southern India. Hong Kong had a particularly high contribution of DAHA, which 
the epidemiologically based method did not account for. This suggests that variations in BAP should not be 
viewed as indicators of variation in human cancer risk due to PAH mixtures, which is a common conclusion 
drawn from atmospheric models of BAP alone.
While toxicity information used in the animal-based method may not be exactly representative of humans, 
it does allow us to compare the individual risk of different species in the PAH mixture. PAHs impart their 
toxic effects on cells through complex pathways that include responses to DNA damage and protein-medi-
ated cellular signaling pathways that alter gene expression of several cytochrome P450s and other enzymes. 
The expression of PAH-responsive enzymes can vary widely between animals and humans, resulting in 
differences in susceptibility to these compounds. However, in this study we used literature values of the rel-
ative toxicities of PAHs compared to BAP, where mechanisms of action for different PAH species are often 
similar between animals and humans. There are no human data on the relative toxicities of these PAHs, 
making us reliant on toxicity data derived from animals where multiple different PAHs have been tested 
individually in animals. Mechanisms for differences in relative toxicities of PAHs and their nitro derivatives 
are not yet well understood; however, in most cases, the differences have been attributed to differences 
in absorption, transport and solubility of compounds in the body (Fu et al., 1990). More comprehensive 
understanding of how these pharmacokinetic parameters differ between animal and humans and among 
different PAH species could further extend the applicability of our animal-based method.
In contrast to previous studies, we found that the cancer risks associated with PAHs are not sensitive to 
uncertainties in heterogeneous oxidation kinetics. As discussed above, when particle-phase PAHs were 
assumed to be less reactive, concentrations of the parent compounds increase at the expense of concen-
trations of the oxidation products. Hence, in the animal-based method for estimating human cancer risk, 
where both emitted PAHs and the degradation products are considered, global ILCR increased by 18%. Con-
trastingly, in the epidemiologically based method for estimating ILCR, which only considers concentrations 
of a single parent compound (BAP), global ILCR increased by 76%. This reduced sensitivity contradicts 
previous results by Shrivastava et al. (2017), who estimated, using an epidemiologically based method, that 
reductions in reactivity (due to a hypothesized mechanism including particle shielding) increased global 
ILCR by a factor of 3, corresponding with five-fold estimates of global-average population-weighted BAP 
concentration. Hence, our holistic view of PAHs, considering both parent compounds and oxidative deriva-
tives, weakens the sensitivity of PAH human cancer risk to uncertainties in heterogeneous oxidation kinet-





partitioning. When then the gas-particle partitioning scheme was changed from the ppLFER to the D&E 
scheme, global cancer risk changed by less than 1%.
Overall, we conclude that BAP is a poor indicator of human health risks, and that other emitted PAHs 
and N-PAHs are the dominant contributors to the human cancer risk of PAHs. Researchers and governing 
bodies should consider extending assessment and monitoring beyond BAP in order to better capture who is 
affected, and how the health impacts could be mitigated. Further understanding of PAHs and their impacts 
will require additional measurements of PAHs in the atmosphere, especially outside North America and 
Europe, increased understanding of the mechanisms and degradation products of PAH oxidation, better 
quantification of the toxicity of PAHs through toxicological and epidemiological studies, and new policy 
frameworks that adequately capture complex pollutant mixtures.
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